IL41902A - Immunogenic substance,its production,vaccine preparations containing it and their preparation - Google Patents

Immunogenic substance,its production,vaccine preparations containing it and their preparation

Info

Publication number
IL41902A
IL41902A IL41902A IL4190273A IL41902A IL 41902 A IL41902 A IL 41902A IL 41902 A IL41902 A IL 41902A IL 4190273 A IL4190273 A IL 4190273A IL 41902 A IL41902 A IL 41902A
Authority
IL
Israel
Prior art keywords
vaccine
substance
immunogenic substance
multocida
immunogenic
Prior art date
Application number
IL41902A
Other languages
English (en)
Other versions
IL41902A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL41902A0 publication Critical patent/IL41902A0/xx
Publication of IL41902A publication Critical patent/IL41902A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL41902A 1972-03-29 1973-03-28 Immunogenic substance,its production,vaccine preparations containing it and their preparation IL41902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1491072 1972-03-29
GB593573*[A GB1441098A (en) 1972-03-29 1973-02-07 Biological preparations

Publications (2)

Publication Number Publication Date
IL41902A0 IL41902A0 (en) 1973-05-31
IL41902A true IL41902A (en) 1976-03-31

Family

ID=26240265

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41902A IL41902A (en) 1972-03-29 1973-03-28 Immunogenic substance,its production,vaccine preparations containing it and their preparation

Country Status (9)

Country Link
JP (1) JPS496118A (US06582424-20030624-M00016.png)
DE (1) DE2315563A1 (US06582424-20030624-M00016.png)
ES (1) ES413100A1 (US06582424-20030624-M00016.png)
FR (1) FR2182909B1 (US06582424-20030624-M00016.png)
GB (1) GB1441098A (US06582424-20030624-M00016.png)
HU (1) HU171383B (US06582424-20030624-M00016.png)
IL (1) IL41902A (US06582424-20030624-M00016.png)
IT (1) IT1035061B (US06582424-20030624-M00016.png)
NL (1) NL7304320A (US06582424-20030624-M00016.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1133829A (en) * 1978-08-24 1982-10-19 Neil J.L. Gilmour Pasteurellosis vaccines
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
NL8200392A (nl) * 1982-02-03 1983-09-01 Duphar Int Res Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
JPH0662433B2 (ja) * 1984-04-23 1994-08-17 財団法人日本生物科学研究所 ヘモフイルス・パラガリナ−ラムの粉状ワクチン製造法
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.

Also Published As

Publication number Publication date
NL7304320A (US06582424-20030624-M00016.png) 1973-10-02
ES413100A1 (es) 1976-06-01
FR2182909B1 (US06582424-20030624-M00016.png) 1976-04-09
IL41902A0 (en) 1973-05-31
IT1035061B (it) 1979-10-20
JPS496118A (US06582424-20030624-M00016.png) 1974-01-19
HU171383B (hu) 1977-12-28
GB1441098A (en) 1976-06-30
FR2182909A1 (US06582424-20030624-M00016.png) 1973-12-14
DE2315563A1 (de) 1973-10-11

Similar Documents

Publication Publication Date Title
EP2932979B1 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
Mourad et al. Passive immunization of mice against Candida albicans
US4451446A (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
IL41902A (en) Immunogenic substance,its production,vaccine preparations containing it and their preparation
Angerman et al. Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium
Egerton Surface and somatic antigens of Fusiformis nodosus
BR112015013513B1 (pt) Composição de conjugado de proteína polissacarídica pneumocócica multivalente
CA2402935A1 (en) Adjuvant for vaccines
US3928565A (en) Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
Abrahams Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis
KR101864029B1 (ko) 다회투여량 혼합 백신 조성물
JP2015091795A (ja) 鼻粘膜ワクチン組成物
WO2010084298A1 (en) Stable vaccine compositions and methods of use
US4057626A (en) Process for detoxifying influenza B virus
US20100183675A1 (en) Stable vaccine compositions and methods of use
Collins et al. Heat-Labile Antigens of Salmonella enteritidis II. Mouse-protection Studies
US3987164A (en) Method for prevention of pseudomonas aeruginosa infections
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
Garçon et al. Development and Evaluation of AS04, a Novel and Improved Adjuvant System Containing 3-O-Desacyl-4′-Monophosphoryl Lipid A and Aluminum Salt
US4287173A (en) Vaccine for dental caries
JPS6236501B2 (US06582424-20030624-M00016.png)
RU2227160C1 (ru) Штамм бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
US20040170652A1 (en) Saponin inactivated mycoplasma vaccine
Geddes et al. Chloramphenicol resistance in the typhoid bacillus.
JPH11240844A (ja) 肺炎球菌抗原の経口投与